|
|
|
|
Institute for Anatomy and Cell Biology, Justus-Liebig-University, Giessen, Germany (N.S., S.S., S.W., A.G., W.K., R.V.H.); and Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive Kidney Diseases, Department of Health and Human Services, Bethesda, Maryland (M.Y., J.W.)
In the airways, increases in cholinergic nerve activity and cholinergic hypersensitivity are associated with chronic obstructive pulmonary disease and asthma. However, the contribution of individual muscarinic acetylcholine receptor subtypes to the constriction of smaller intrapulmonary airways that are primarily responsible for airway resistance has not been analyzed. To address this issue, we used videomicroscopy and digital imaging of precision-cut lung slices derived from wild-type mice and mice deficient in either the M1 (mAChR1-/- mice), M2 (mAChR2-/- mice), or M3 receptor subtype (mAChR3-/- mice) or lacking both the M2 and M3 receptor subtypes (mAChR2/3-/- double-knockout mice). In peripheral airways from wild-type mice (mAChR+/+ mice), muscarine induced a triphasic concentration-dependent response, characterized by an initial constriction, a transient relaxation, and a sustained constriction. The bronchoconstriction was diminished by up to 60% in mAChR3-/- lungs and was completely abolished in mAChR2/3-/- lungs. The sustained bronchoconstriction was reduced in mAChR2-/- bronchi, and, interestingly, the transient relaxation was absent; the bronchoconstriction in response to 10-8 M muscarine was increased by 158% in mAChR1-/- mice. Quantitative reverse transcriptase-polymerase chain reaction analysis revealed that the disruption of specific mAChR genes had no significant effect on the expression levels of the remaining mAChR subtypes. These results demonstrate that cholinergic constriction of murine peripheral airways is mediated by the concerted action of the M2 and M3 receptor subtypes and suggest the existence of pulmonary M1 receptor activation, which counteracts cholinergic bronchoconstriction. Given the important role of muscarinic cholinergic mechanisms in pulmonary disease, these findings should be of considerable therapeutic relevance.
Received April 4, 2003; accepted September 5, 2003.
Address correspondence to: Dr. R.V. Haberberger, Institut fur Anatomie and Zellbiologie, Autweg 123, D-35385 Gliessen, Germany. E-mail: rainer.v.haberberger{at}anatomie.med.uni-giessen.de
This article has been cited by other articles:
![]() |
T. Kitazawa, K. Asakawa, T. Nakamura, H. Teraoka, T. Unno, S.-i. Komori, M. Yamada, and J. Wess M3 Muscarinic Receptors Mediate Positive Inotropic Responses in Mouse Atria: A Study with Muscarinic Receptor Knockout Mice J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Singh, N. C. Mishra, J. Rir-sima-ah, M. Campen, V. Kurup, S. Razani-Boroujerdi, and M. L. Sopori Maternal Exposure to Secondhand Cigarette Smoke Primes the Lung for Induction of Phosphodiesterase-4D5 Isozyme and Exacerbated Th2 Responses: Rolipram Attenuates the Airway Hyperreactivity and Muscarinic Receptor Expression but Not Lung Inflammation and Atopy J. Immunol., August 1, 2009; 183(3): 2115 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Klein, R. V. Haberberger, P. Hartmann, P. Faulhammer, K. S. Lips, B. Krain, J. Wess, W. Kummer, and P. Konig Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development Eur. Respir. J., May 1, 2009; 33(5): 1113 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. F. Fonseca, P. C. Olsen, L. P. Coelho, T. P. T. Ferreira, H. S. Souza, M. A. Martins, and J. P. B. Viola NFAT1 Transcription Factor Regulates Pulmonary Allergic Inflammation and Airway Responsiveness Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 66 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Deshpande, B. S. Theriot, R. B. Penn, and J. K. L. Walker {beta}-Arrestins specifically constrain {beta}2-adrenergic receptor signaling and function in airway smooth muscle FASEB J, July 1, 2008; 22(7): 2134 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Braverman, R. J. Tallarida, and M. R. Ruggieri Sr. The Use of Occupation Isoboles for Analysis of a Response Mediated by Two Receptors: M2 and M3 Muscarinic Receptor Subtype-Induced Mouse Stomach Contractions J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 954 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Penn and J. L. Benovic Regulation of Heterotrimeric G Protein Signaling in Airway Smooth Muscle Proceedings of the ATS, January 1, 2008; 5(1): 47 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakamoto, T. Unno, T. Kitazawa, T. Taneike, M. Yamada, J. Wess, M. Nishimura, and S. Komori Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells J. Physiol., July 1, 2007; 582(1): 41 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeda, N. Hizawa, E. Jinushi, A. Honda, D. Takahashi, Y. Fukui, S. Konno, T. Shimizu, H. Shimizu, E. Yamaguchi, et al. Polymorphisms in the Muscarinic Receptor 1 Gene Confer Susceptibility to Asthma in Japanese Subjects Am. J. Respir. Crit. Care Med., November 15, 2006; 174(10): 1119 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Mazzone, N. Mori, M. Burman, M. Palovich, K. E. Belmonte, and B. J. Canning Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy J. Physiol., August 15, 2006; 575(1): 23 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Allen, J. M. Hartney, T. M. Coffman, R. B. Penn, J. Wess, and B. H. Koller Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L526 - L533. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lips, C. Volk, B. M. Schmitt, U. Pfeil, P. Arndt, D. Miska, L. Ermert, W. Kummer, and H. Koepsell Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gautam, S.-J. Han, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 995 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gautam, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess Cholinergic Stimulation of Salivary Secretion Studied with M1 and M3 Muscarinic Receptor Single- and Double-Knockout Mice Mol. Pharmacol., August 1, 2004; 66(2): 260 - 267. [Abstract] [Full Text] [PDF] |
||||